NowPatient Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: Brand-name GLP-1 access without a compounded route
NowPatient scores highest on the strength of its clinical program: drug options and dosing support.
What the plan covers
Medication
Included
Provider visits
Included
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
NowPatient is a US-UK telehealth platform that prescribes brand-name weight-loss medicines only: Mounjaro, Wegovy (injection and tablet), Saxenda and Foundayo. The consultation is free and you pay for the medication. Prices are listed per pack, not per month, and rise with strength: the lowest-strength packs start at $99 for 30 Wegovy tablets, $113.85 for 30 Foundayo tablets, $215.98 for a Wegovy pen and $251.98 for a Mounjaro pen, plus a shipping and import duties charge.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to NowPatient
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
NowPatient at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $99 total
- What's included
- Medication · Consult
- FDA status
- No FDA warning letter on record
How we scored NowPatient
Each dimension is scored algorithmically from NowPatient’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.2/10NowPatient does not post a standard monthly cash price up front, so cost transparency is limited. Confirm the ongoing rate before you commit.
Effectiveness25%
8.3/10NowPatient offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. It prescribes FDA-approved brand-name medication rather than compounded versions.
User Experience15%
7.0/10Online intake and platform experience (consult included in the price); 2 platform features disclosed.
Trust & Safety15%
7.2/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.0/10NowPatient's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.8/10NowPatient provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this NowPatient review
Last checked November 2026- Confirmed current pricing across 5 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $99–$441/mo across 5 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with NowPatient
We walked NowPatient’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Search for the treatment/condition.
- 2Complete a health profile.
- 3Book a consultation (slots up to 7 days ahead).
- 4Attend a video consultation with a clinician.
- 5Receive the treatment if prescribed (delivered by post).
- GLP-1 meds listed: Mounjaro, Wegovy injection & tablets, Saxenda (UK brand names for a UK-centric service).
- Each treatment page shows the price of the default pack, a shipping and import duties line and a 'Total if approved' figure before you start; the consultation itself is free.
- Blood-pressure readings are required for certain medications via a cuffless smartphone-camera method (not lab bloodwork).
- A video consultation is explicitly part of the flow.
NowPatient customer support
- Hours
- Mon-Fri 8am-5pm EST (US); Mon-Fri 9am-6pm GMT (UK)
GLP-1 medications NowPatient offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Lowest strength, smallest pack. The treatment page adds $75.00 for shipping and import duties.
Lowest strength, smallest pack. The treatment page adds $75.00 for shipping and import duties.
30 tablets at the lowest strength. The treatment page adds $20.00 for shipping and import duties.
Smallest pack. The treatment page adds $75.00 for shipping and import duties.
30 tablets at the lowest strength. The treatment page adds $20.00 for shipping and import duties.
Ready to get started?
Plans and promotions change often, so check NowPatient's current pricing and active discounts before you decide.
What we like
- Free telehealth consultation; you only pay for the medication
- Brand-name Mounjaro, Wegovy injection and tablets, Saxenda and Foundayo all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options: every drug is FDA-approved brand-name
Watch-outs
- Prices are per pack and rise with strength, and each order adds a shipping and import duties charge
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
NowPatient: an all-brand GLP-1 route with a free consult and no premium on the drug
NowPatient is unusual in a market that runs on compounded copies. It's a US-UK telehealth platform, headquartered in Austin, that prescribes only FDA-approved brand-name weight-management medicines: Mounjaro, Wegovy as both an injection and an oral tablet, Saxenda and Foundayo. The pitch is simple and open about its own economics: the consultation is free, and you pay only for the cost of the medication itself. If you specifically want the branded drug and not a pharmacy-compounded version, NowPatient is built for you. If you came here hunting for the cheapest possible monthly price, this is almost certainly not your provider.
How the pricing works: free visit, brand list price for the drug
There is no membership, no program fee, and no consult charge. NowPatient's own FAQ states it plainly: 'the consultation itself is completely free,' and if a clinician prescribes medication, 'you only pay for the cost of the medication' and nothing else. The medication is the full branded product, though, so your out-of-pocket effectively tracks each manufacturer's cash list price. The pricing basis is the thing most likely to mislead you here: every figure NowPatient publishes is the price of a pack, and the site never puts the word 'month' beside any of them. The entry price is $251.98 for a Mounjaro pack at the lowest strength, $215.98 for a Wegovy injection pack, and $440.82 for Saxenda. Each of those is the smallest pack at the lowest dose. They are floors, not what a maintenance dose will cost you. The low figures are for tablets: $99 buys 30 Wegovy tablets at 1.5mg and $113.85 buys 30 Foundayo tablets at 0.8mg, each a month's worth of pills only if your dose stays at the bottom of the ladder. Every order also carries a shipping and import duties line, $75 on pens and $20 on tablets, which the treatment page adds into a "Total if approved" figure.
To put that in perspective, the category median monthly price is about $179, a figure built largely on compounded semaglutide and tirzepatide. NowPatient sits many multiples above that line because brand-name GLP-1s cost what they cost when you pay cash, not because it marks the drug up. You're trading price for the brand.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
The medication catalog, including the rare oral Wegovy option
NowPatient's weight-management lineup covers four molecules: tirzepatide as Mounjaro, semaglutide as Wegovy, liraglutide as Saxenda, and orforglipron as Foundayo. Wegovy comes in both the familiar weekly injection and the newer oral tablet, and NowPatient is one of the few places you'll find the pill version at all. With Foundayo as a second daily pill, people who dread needles have a concrete reason to look here rather than at a compounding-only clinic.
- Mounjaro (tirzepatide injection): the weekly pen, from $251.98 at the lowest strength
- Wegovy injection (semaglutide): the standard weekly pen, from $215.98
- Wegovy oral tablet (semaglutide): the needle-free pill, rarely offered elsewhere, from $99 for 30 tablets
- Foundayo (orforglipron tablet): a daily pill with no fasting rule, from $113.85 for 30 tablets
- Saxenda (liraglutide injection): an older daily-injection option, from $440.82 for five pens
Brand-only, with no premium on the drug
NowPatient is all-brand by design, with no compounded semaglutide or tirzepatide anywhere in the catalog. Every drug you can get is the FDA-approved product straight from the manufacturer, which removes the formulation-quality and sourcing questions that hang over the compounded market. It also doesn't pad the bill: no premium on the medicine, no consult fee, no monthly platform charge. The price you see is essentially the drug's own price, and the visit that gets you there costs nothing. Few platforms pair a brand-only menu with zero premium. TeleSlim Clinic is another brand-only route, run by obesity-medicine physicians who send prescriptions to your own pharmacy in six states.
Who should choose it, and who should skip it
Choose NowPatient if you want the branded drug, value a transparent fee structure, or specifically need the oral Wegovy tablet. It also suits people who plan to use insurance or a manufacturer savings card against a brand prescription, since you're holding a legitimate brand-name script rather than a compounded one. In California, JumpstartMD adds in-person visits and coaching, with 14 clinics plus online care and physicians who prescribe brand-name GLP-1s.
Skip it if budget is your top priority. Compounded semaglutide and tirzepatide from other providers usually land a fraction of the cost, and paying brand list price out of pocket is a heavy lift for most people. A few practical frictions matter too: NowPatient doesn't publish which states it serves (that's sorted during intake, not shown upfront), and every price is per pack, so working out a monthly cost is left to you.
Trust, safety, and medical oversight
On the safety ledger, NowPatient looks clean. There are no FDA warning letters against it, and because it dispenses only approved brand-name medication, there's no compounding pharmacy partner whose accreditation you'd need to scrutinize. The free-consultation model is clinician-gated: a prescriber has to write the script before you pay for anything. The main caveat is transparency around logistics: the published state list and any shipping terms are thin on the US side, so confirm coverage for your state and your total delivered cost during the free intake before you commit. You can see how we weigh these factors in our scoring methodology.
Bottom line
NowPatient is a clean, honest, brand-only GLP-1 provider for people who want the branded drug and a no-fee path to it, and it's one of the only places offering Wegovy as a pill. Go in clear-eyed on two things. You're paying full brand price: $215.98 for the cheapest injection pack, $251.98 for Mounjaro. And you're buying by the pack, not by the month, at the lowest dose in each range, so budget above those figures, not at them, and add the shipping and import duties line ($75 on pens, $20 on tablets) to each order. If that's the trade you want, NowPatient makes it about as straightforward and premium-free as brand-name GLP-1 access gets. If you'd rather save money with a compounded route, look elsewhere.
The Bottom Line
NowPatient scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with NowPatient?
See current pricing and start your free consultation.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this NowPatient review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See NowPatient's current pricing
Start your free consultation to check eligibility and today's price.